Skip navigation
Please use this identifier to cite or link to this item: https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/98
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAherne, N. J.-
dc.contributor.authorRangaswamy, G.-
dc.contributor.authorThirion, P.-
dc.date.accessioned2024-11-26T05:32:49Z-
dc.date.available2024-11-26T05:32:49Z-
dc.date.issued2013-
dc.identifier.citationCase reports in urology. 2013:2013:405343. doi: 10.1155/2013/405343. Epub 2013 Aug 5.en
dc.identifier.urihttps://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/98-
dc.description.abstractHolt-Oram syndrome is an autosomal dominant disorder which is caused by mutations of TBX5 and is characterised by cardiac and skeletal abnormalities. TBX5 is part of the T-box gene family and is thought to upregulate tumour cell proliferation and metastasis when mutated. We report the first clinical case of prostate cancer in an individual with Holt Oram syndrome.en
dc.language.isoenen
dc.subjectHolt-Oram Syndromeen
dc.subjectProstatic Neoplasmsen
dc.titleProstate cancer in a male with Holt-Oram Syndrome: First clinical association of the TBX5 mutationen
dc.typeArticleen
dc.contributor.mnclhdauthorAherne, Noel-
Appears in Collections:Oncology / Cancer
Urology

Files in This Item:
File SizeFormat  
CRIM.UROLOGY2013-405343.pdf682.19 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing